Lynn Anne Bristol

Array ( [id] => 8277367 [patent_doc_number] => 20120171242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'Modified Antibody' [patent_app_type] => utility [patent_app_number] => 13/353548 [patent_app_country] => US [patent_app_date] => 2012-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 10704 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13353548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8197105 [patent_doc_number] => 20120121620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'ANTI-ESTROGEN AND IMMUNE MODULATOR COMBINATIONS FOR TREATING BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 13/349311 [patent_app_country] => US [patent_app_date] => 2012-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9597 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121620.pdf [firstpage_image] =>[orig_patent_app_number] => 13349311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9093738 [patent_doc_number] => 20130273049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'ROBO1-FC FUSION PROTEIN FOR USE IN THE TREATMENT OF HEPATOCARCINOMA' [patent_app_type] => utility [patent_app_number] => 13/996689 [patent_app_country] => US [patent_app_date] => 2011-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8384 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8158338 [patent_doc_number] => 20120100101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'CTLA-4 ANTIBODY DOSAGE ESCALATION REGIMENS' [patent_app_type] => utility [patent_app_number] => 13/335232 [patent_app_country] => US [patent_app_date] => 2011-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12141 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100101.pdf [firstpage_image] =>[orig_patent_app_number] => 13335232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9448921 [patent_doc_number] => 20140120090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-01 [patent_title] => 'CROSS-LINKING POLYPEPTIDE THAT INDUCES APOPTOSIS' [patent_app_type] => utility [patent_app_number] => 13/976952 [patent_app_country] => US [patent_app_date] => 2011-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13794 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13976952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335047 [patent_doc_number] => 20120201751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44' [patent_app_type] => utility [patent_app_number] => 13/310917 [patent_app_country] => US [patent_app_date] => 2011-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 31117 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13310917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16970522 [patent_doc_number] => 11066483 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-20 [patent_title] => Cytotoxicity-inducing therapeutic agent [patent_app_type] => utility [patent_app_number] => 13/990088 [patent_app_country] => US [patent_app_date] => 2011-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 38232 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 484 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8172313 [patent_doc_number] => 20120107874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'Modified Host Cells and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/306777 [patent_app_country] => US [patent_app_date] => 2011-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 28718 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107874.pdf [firstpage_image] =>[orig_patent_app_number] => 13306777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8044307 [patent_doc_number] => 20120071860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'DENDRITIC CELL TUMOR INJECTION (DCTI) THERAPY' [patent_app_type] => utility [patent_app_number] => 13/303679 [patent_app_country] => US [patent_app_date] => 2011-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9583 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071860.pdf [firstpage_image] =>[orig_patent_app_number] => 13303679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9895087 [patent_doc_number] => 20150050286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'ANTI-NGF ANTIBODIES AND METHODS USING SAME' [patent_app_type] => utility [patent_app_number] => 13/302264 [patent_app_country] => US [patent_app_date] => 2011-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 58442 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13302264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7790518 [patent_doc_number] => 20120052074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'HUMAN MONOCLONAL ANTIBODIES TO ACTIVIN RECEPTOR-LIKE KINASE-1' [patent_app_type] => utility [patent_app_number] => 13/282065 [patent_app_country] => US [patent_app_date] => 2011-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 54181 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20120052074.pdf [firstpage_image] =>[orig_patent_app_number] => 13282065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8771958 [patent_doc_number] => 08425911 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Methods of treating secondary bone tumors with antibodies against PDGFR alpha' [patent_app_type] => utility [patent_app_number] => 13/276358 [patent_app_country] => US [patent_app_date] => 2011-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 18948 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13276358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754619 [patent_doc_number] => 20120027767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'ANTIBODIES AGAINST PDGFR ALPHA TO INHIBIT TUMOR GROWTH' [patent_app_type] => utility [patent_app_number] => 13/276353 [patent_app_country] => US [patent_app_date] => 2011-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18915 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027767.pdf [firstpage_image] =>[orig_patent_app_number] => 13276353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8323450 [patent_doc_number] => 20120195855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'METHODS FOR UP-REGULATING ANTIGEN EXPRESSION IN TUMORS' [patent_app_type] => utility [patent_app_number] => 13/276783 [patent_app_country] => US [patent_app_date] => 2011-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19868 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13276783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7766128 [patent_doc_number] => 20120034206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'BREAST CANCER ERADICATION PROGRAM' [patent_app_type] => utility [patent_app_number] => 13/273382 [patent_app_country] => US [patent_app_date] => 2011-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17238 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034206.pdf [firstpage_image] =>[orig_patent_app_number] => 13273382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757424 [patent_doc_number] => 20120029171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Method of Producing a Plurality of Isolated Antibodies to a Plurality of Cognate Antigens' [patent_app_type] => utility [patent_app_number] => 13/253366 [patent_app_country] => US [patent_app_date] => 2011-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7220 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029171.pdf [firstpage_image] =>[orig_patent_app_number] => 13253366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744186 [patent_doc_number] => 20120021948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'SURFACE DISPLAY OF WHOLE ANTIBODIES IN EUKARYOTES' [patent_app_type] => utility [patent_app_number] => 13/251410 [patent_app_country] => US [patent_app_date] => 2011-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 29352 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021948.pdf [firstpage_image] =>[orig_patent_app_number] => 13251410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8652845 [patent_doc_number] => 08372591 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease' [patent_app_type] => utility [patent_app_number] => 13/247614 [patent_app_country] => US [patent_app_date] => 2011-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12902 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13247614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742077 [patent_doc_number] => 20120020880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44' [patent_app_type] => utility [patent_app_number] => 13/243870 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23413 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020880.pdf [firstpage_image] =>[orig_patent_app_number] => 13243870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656362 [patent_doc_number] => 20110305631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Camptothecin Conjugates of Anti-CD22 Antibodies for Treatment of B Cell Diseases' [patent_app_type] => utility [patent_app_number] => 13/213245 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 44132 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305631.pdf [firstpage_image] =>[orig_patent_app_number] => 13213245 [rel_patent_id] =>[rel_patent_doc_number] =>)